Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Sarcoma chemotherapy.

Walczak BE, Irwin RB.

J Am Acad Orthop Surg. 2013 Aug;21(8):480-91. doi: 10.5435/JAAOS-21-08-480. Review.

PMID:
23908254
2.

The value of adjuvant chemotherapy in the management of sarcomas in children.

Donaldson SS.

Cancer. 1985 May 1;55(9 Suppl):2184-97. Review.

3.

Chemotherapy of advanced sarcomas of bone and soft tissue.

Antman KH.

Semin Oncol. 1992 Dec;19(6 Suppl 12):13-20. Review.

PMID:
1485169
4.

[Soft tissue sarcoma: postoperative chemotherapy].

Goto T, Kosaku H, Kobayashi H, Hozumi T, Kondo T.

Gan To Kagaku Ryoho. 2004 Sep;31(9):1324-30. Review. Japanese.

PMID:
15446551
5.

[Preoperative adjuvant therapy for primary malignant bone tumors].

Goto T, Okuma T, Nakada I, Hozumi T, Kondo T.

Gan To Kagaku Ryoho. 2007 Nov;34(11):1750-4. Japanese.

PMID:
18030009
6.

Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma Group.

Blackledge G, Steward WP, Verweij J, Mouridsen H, Bramwell V, Schütte J, van Oosterom A, Dombernowsky P, Buesa J, Van Glabekke M, et al.

Semin Oncol. 1992 Feb;19(1 Suppl 1):14-8. Review.

PMID:
1411615
7.

[Chemotherapy of advanced bone and soft tissue sarcoma].

Yamawaki S, Isu K, Ubayama Y, Yamaguti H, Gotou M.

Gan To Kagaku Ryoho. 1984 Sep;11(9):1757-63. Japanese.

PMID:
6541020
8.

Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Granowetter L, Womer R, Devidas M, Krailo M, Wang C, Bernstein M, Marina N, Leavey P, Gebhardt M, Healey J, Shamberger RC, Goorin A, Miser J, Meyer J, Arndt CA, Sailer S, Marcus K, Perlman E, Dickman P, Grier HE.

J Clin Oncol. 2009 May 20;27(15):2536-41. doi: 10.1200/JCO.2008.19.1478. Epub 2009 Apr 6.

9.
10.
11.

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experience.

Navid F, Santana VM, Billups CA, Merchant TE, Furman WL, Spunt SL, Cain AM, Rao BN, Hale GA, Pappo AS.

Cancer. 2006 Apr 15;106(8):1846-56.

12.

[Medical treatment of soft-tissue sarcomas in adults].

Lucas P, Spielmann M.

Bull Cancer. 1985;72(3):183-201. Review. French.

PMID:
3907733
13.

Chemotherapy of advanced soft-tissue sarcomas.

Antman KH, Elias AD.

Semin Surg Oncol. 1988;4(1):53-8. Review.

PMID:
3281212
14.

High-dose ifosfamide in the treatment of sarcomas of soft tissues and bone.

Demetri GD.

Semin Oncol. 1996 Jun;23(3 Suppl 6):22-6. Review.

PMID:
8677444
15.

Soft-tissue and bone sarcomas.

Scurr M, Judson I.

Cancer Chemother Biol Response Modif. 2005;22:591-604. Review. No abstract available.

PMID:
16110630
16.
17.
18.

Ifosfamide and etoposide plus vincristine, doxorubicin, and cyclophosphamide for newly diagnosed Ewing's sarcoma family of tumors.

Wexler LH, DeLaney TF, Tsokos M, Avila N, Steinberg SM, Weaver-McClure L, Jacobson J, Jarosinski P, Hijazi YM, Balis FM, Horowitz ME.

Cancer. 1996 Aug 15;78(4):901-11. Erratum in: Cancer 1997 Feb 15;79(4):867.

19.

Alternatives to CYVADIC combination therapy of soft tissue sarcomas.

Hartlapp JH, Münch HJ, Illiger HJ, Wolter H, Jensen JC.

Cancer Chemother Pharmacol. 1986;18 Suppl 2:S20-2.

PMID:
3815715
20.

[Current strategy of chemotherapy for reflactory bone and soft tissue sarcomas].

Chuman H.

Gan To Kagaku Ryoho. 2004 Sep;31(9):1331-9. Review. Japanese.

PMID:
15446552

Supplemental Content

Support Center